Author:
David H.Rubin
David A.Perlstein
Description
- Defect in the type, amount, and toxicity of metabolites that accumulate due to inherited defects in metabolic pathways of enzymes, cofactors, or transporters that result in a variety of clinical findings; >500 human diseases are caused by inborn errors of metabolism
- Epidemiology:
- Genetics:
- Common inherited metabolic diseases:
- Amino acid disorders
- Urea cycle defects
- Organic acidemias
- Defects in fatty acid oxidation
- Mitochondrial fatty acid defects and carnitine transport defects
- Mitochondrial disease
- Carbohydrate disorders
- Mucopolysaccharidoses
- Sphingolipidoses
- Peroxisomal disorders
- Protein glycosylation disorders
- Lysosomal disorders
- Rhizomelic chondrodysplasia punctata
- Pathophysiology:
- Related to defect in a metabolic pathway
Etiology
Diverse group of disorders involving genetic deficiency of an enzyme of an intermediary metabolite or a membrane transport system
Signs and Symptoms
- Disorders may present with either a rapid decompensation or a chronic indolent course
- Neonates, initial presentation:
- Asymptomatic
- Hypothermia (mitochondrial defects)
- Hypotonia/hypertonia (peroxisomal disorders)
- Apnea (urea cycle defects, organic acidosis)
- Seizures (peroxisomal disorders, glucose transporter defects)
- Lethargy, coma (numerous)
- Vomiting (numerous)
- Poor feeding, growth (numerous)
- Jaundice (galactosemia, Niemann-Pick C)
- Hypoglycemia (galactosemia, maple syrup urine), hepatomegaly, liver failure
- Dysmorphic features (lysosomal storage disorders, congenital adrenal hyperplasia, Smith-Lemli-Opitz)
- Older children, untreated:
- Failure to thrive (urea cycle defects)
- Dehydration (organic acidosis)
- Vomiting (urea cycle defects and others)
- Diarrhea (numerous)
- Food intolerance (lipid defects, amino acid defects)
- Lethargy (urea cycle defects)
- Ataxia (urea cycle defects)
- Seizures (numerous)
- Mental retardation (phenylketonuria and others)
History
Complete history of current and concomitant illness:
- Newborn screening
- Dietary
- Family
- Consanguinity
- Other
Physical Exam
- Abnormal odor
- Altered mental status
- Tachypnea
- Abnormal facies
- Cataract
- Cardiomyopathy
- Hepatomegaly
- Splenomegaly
- Dermatitis
- Jaundice
Essential Workup
Key is to consider in differential diagnosis:
- Deteriorating neurologic status
- Unexplained failure to thrive, with dehydration, persistent vomiting, or acidosis
- Shock unresponsive to conventional resuscitative measures
Diagnostic Tests & Interpretation
Lab
- Bedside glucose determination
- Electrolytes, BUN/creatinine, glucose
- CBC with differential
- Calcium level
- LFTs, fractionated bilirubin, PTT
- Arterial or venous blood gas
- Lactate and pyruvate level
- Uric acid
- Urinalysis: Reducing substances, ketones, pH
- Chemistries:
- Ammonia level
- Quantitative serum amino acids, acylcarnitine profile
- Urine organic and amino acids
- Cultures:
- Blood
- CSF: Including amino acids, neurotransmitters
Imaging
- CT scan of head for altered mental status
- CXR
Diagnostic Procedures/Surgery
Lumbar puncture
Differential Diagnosis
- Often misdiagnosed as sepsis, dehydration, failure to thrive, toxic ingestion, or nonaccidental trauma
- Infection:
- Sepsis
- Meningitis
- Encephalitis
- Metabolic:
- Reye syndrome
- Hepatic encephalopathy
- Hyperinsulinemia
- Hormonal abnormality
- Renal:
- Renal failure
- Renal tubular acidosis
- Toxic ingestion
- CNS mass lesions
- Nonaccidental trauma
Prehospital
ALERT |
- ABCs
- Bedside glucose
- IV glucose infusion takes precedence over fluid boluses unless patient in shock. Correction can occur concurrently
- Avoid lactated Ringer solution
- Keep child NPO
|
Initial Stabilization/Therapy
For altered mental status, administer Narcan, glucose (ideally after Accu-Chek and thiamine)
ED Treatment/Procedures
- Establish airway, breathing, and circulation
- Normal saline 10 mL/kg (neonates and patients with heart failure), 20 mL/kg (infants and children); avoid lactated Ringer and hypotonic fluid
- If hypoglycemic, give IV glucose bolus at 0.25-1.0 g/kg D10 for neonates and D10 or D25 if older; maintenance D10-D15 at rate of 8-12 mg/kg/min of glucose to maintain serum glucose level at 120-170 mg/dL
- After glucose bolus, start D10-D15 in ½ normal saline at 1-1.5 maintenance
- If patient is severely hypoglycemic, give IV glucose bolus of D25
- Rehydrate if patient is hypoglycemic:
- Restore normal acid-base balance
- Administer bicarbonate and /or potassium acetate slowly if pH is <7.0:
- Initiate dialysis if severe acidosis does not improve quickly
- Increase urine output to help in removal of some toxins
- Initially, stop all oral intake; amino acid metabolites may be neurotoxic
- Treat severe hyperammonemia (≥300-600 mmol/L) with immediate dialysis or with ammonia-trapping drugs such as:
- Arginine hydrochloride
- Sodium benzoate
- Sodium phenylacetate
- Sodium phenylbutyrate
- Doses vary with disease; consult metabolic physician before use
- Identify and treat intercurrent or precipitating infection/illness
- Consult metabolic physician when any child presents with suspected inherited metabolic disease
Medication
First Line
Glucose:
- If hypoglycemic, give IV glucose bolus at 0.25-1.0 g/kg D10 for neonates and D10 or D25 if older
Second Line
Bicarbonate therapy for pH <7.0:
Disposition
Admission Criteria
- Infants and children presenting with new onset of suspected inherited metabolic disease
- Significant urinary ketones or not tolerating oral intake
- ICU:
- Significant altered mental status
- Severe or persistent acidosis
- Unresponsive hypoglycemia
- Hyperammonemia
- Transfer to specialized pediatric center may be indicated
Discharge Criteria
- Normal mental status
- Normal hydration with unremarkable labs
- No evidence of significant intercurrent illness
- Close follow-up arranged with primary care physician
Issues for Referral
Neurodevelopment:
Follow-up Recommendations
- Primary care physician
- Metabolic disease specialist